About
Technology
Issues
FAQ
Links
Official Page
Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.